Ventilatory control in ALS

Respiratory Physiology and Neurobiology

Volumn 189, Issue 2, 2013, Pages 429-437

  Nichols, Nicole L ^a   Van Dyke, J ^a   Nashold, L ^a   Satriotomo, I ^a   Suzuki, M ^a   Mitchell, G S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Breathing; Compensation; Motor neuron disease; Neurodegenerative disease; Plasticity; Ventilatory control

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; BREATHING; BREATHING MUSCLE; CELL DEATH; CLINICAL FEATURE; COMPENSATION; DEGENERATIVE DISEASE; DISEASE COURSE; HUMAN; MOTONEURON; MOTOR NEURON DISEASE; MUSCLE WEAKNESS; PARALYSIS; PLASTICITY; PRIORITY JOURNAL; RESPIRATION CONTROL; REVIEW;

BREATHING; COMPENSATION; MOTOR NEURON DISEASE; NEURODEGENERATIVE DISEASE; PLASTICITY; VENTILATORY CONTROL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS; INTERMITTENT POSITIVE-PRESSURE VENTILATION; NERVE NET; NONINVASIVE VENTILATION; PULMONARY VENTILATION; RESPIRATORY CENTER;

EID: 84886296826     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2013.05.016     Document Type: Review

References (140)

1. Aboussouan L.S. Mechanisms of exercise limitation and pulmonary rehabilitation for patients with neuromuscular disease. Chronic Respiratory Disease 2009, 6(4):231-249.
2. Alexianu M.E., Ho B.K., Mohamed A.H., La Bella V., Smith R.G., Appel S.H. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Annals of Neurology 1994, 36:846-858.
3. Amano T., Yamakuni T., Okabe N., Sakimura K., Takahashi Y. Production of nerve growth factor in rat skeletal muscle. Neuroscience Letters 1991, 132:5-7.
4. Andersen P.M., Sims K.B., Xin W.W., Kiely R., O'Neill G., Ravits J., Pioro E., Harati Y., Brower R.D., Levine J.S., Heinicke H.U., Seltzer W., Boss M., Brown R.H. Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes. Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology. Research Group on Motor Neuron Diseases 2003, 4:62-73.
5. Arnulf I., Similowski T., Salachas F., Garma L., Mehiri S., Attali V., Behin-Bellhesen V., Meininger V., Derenne J.P. Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis. American Journal of Respiratory and Critical Care Medicine 2000, 161:849-856.
6. Atalaia A., De Carvalho M., Evangelista T., Pinto A. Sleep characteristics of amyotrophic lateral sclerosis in patients with preserved diaphragmatic function. Amyotrophic Lateral Sclerosis 2007, 8:101-105.
7. Baker-Herman T.L., Fuller D.D., Bavis R.W., Zabka A.G., Golder F.J., Doperalski N.J., Johnson R.A., Watters J.J., Mitchell G.S. BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nature Neuroscience 2004, 7:48-55.
8. 2 and ventilatory reflexes in humans. Journal of Applied Physiology 1981, 51:660-664.
9. Banzett R.B., Mulnier H.E., Murphy K., Rosen S.D., Wise R.J., Adams L. Breathlessness in humans activates insular cortex. Neuroreport 2000, 11:2117-2120.
10. Benditt J.O. The neuromuscular respiratory system: physiology, pathophysiology, and a respiratory care approach to patients. Respiratory Care 2006, 51:829-837. (discussion 837-829).
11. Bizovicar N., Zidar I., Koritnik B., Zidar J. Inspiratory- and finger-flexion-related cortical potentials in patients with amyotrophic lateral sclerosis-an exploratory study. Clinical Neurology and Neurosurgery 2012, 114:455-459.
12. Blitz D.M., Ramirez J.M. Long-term modulation of respiratory network activity following anoxia in vitro. Journal of Neurophysiology 2002, 87(6):2964-2971.
13. Boillee S., Vande Velde C., Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006, 52:39-59.
14. Bolser D.C., Jefferson S.C., Rose M.J., Tester N.J., Reier P.J., Fuller D.D., Davenport P.W., Howland D.R. Recovery of airway protective behaviors after spinal cord injury. Respiratory Physiology & Neurobiology 2009, 169:150-156.
15. Bossy-Wetzel E., Schwarzenbacher R., Lipton S.A. Molecular pathways to neurodegeneration. Nature Medicine 2004, 10(Suppl.):S2-S9.
16. Bourke S.C., Shaw P.J., Gibson G.J. Respiratory function vs sleep-disordered breathing as predictors of QOL in ALS. Neurology 2001, 57:2040-2044.
17. Bruijn L.I., Miller T.M., Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annual Review of Neuroscience 2004, 27:723-749.
18. Buffelli M., Pasino E., Cangiano A. Paralysis of rat skeletal muscle equally affects contractile properties as does permanent denervation. Journal of Muscle Research and Cell Motility 1997, 18:683-695.
19. Carreras I., Yuruker S., Aytan N., Hossain L., Choi J.K., Jenkins B.G., Kowall N.W., Dedeoglu A. Moderate exercise delays the motor performance decline in a transgenic model of ALS. Brain Research 2010, 1313:192-201.
20. Cedarbaum J.M., Stambler N. Disease status and use of ventilatory support by ALS patients. BDNF Study Group. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2001, 2(1):19-22.
21. Charcot J., Joffroy A. Deux cas d'atrophie musculaire progressive avec lesion de la substance grise et des faisceaux antero-lateraux de la moelle epiniere. Archiv fur Psychologie Normale et Pathologique 1869, 745-760.
22. Cifra A., Nani F., Nistri A. Respiratory motoneurons and pathological conditions: lessons from hypoglossal motoneurons challenged by excitotoxic or oxidative stress. Respiratory Physiology & Neurobiology 2011, 179:89-96.
23. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature reviews. Neuroscience 2001, 2:806-819.
24. Cluskey S., Ramsden D.B. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Molecular Pathology 2001, MP 54:386-392.
25. Corcia P., Pradat P.F., Salachas F., Bruneteau G., Forestier N., Seilhean D., Hauw J.J., Meininger V. Causes of death in a post-mortem series of ALS patients. Amyotrophic Lateral Sclerosis 2008, 9:59-62.
26. Czaplinski A., Yen A.A., Appel S.H. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. Journal of Neurology, Neurosurgery, and Psychiatry 2006, 77:390-392.
27. Czerwinski S.M., Novakofski J., Bechtel P.J. Modulation of IGF mRNA abundance during muscle denervation atrophy. Medicine and Science in Sports and Exercise 1993, 25:1005-1008.
28. Dadon-Nachum M., Melamed E., Offen D. The dying-back phenomenon of motor neurons in ALS. Journal of Molecular Neuroscience 2011, 43:470-477.
29. de Almeida J.P., Silvestre R., Pinto A.C., deCarvalho M. Exercise and amyotrophic lateral sclerosis. Neurological Sciences 2012, 33(1):9-15.
30. de Carvalho M., Matias T., Coelho F., Evangelista T., Pinto A., Luis M.L. Motor neuron disease presenting with respiratory failure. Journal of the Neurological Sciences 1996, 139(Suppl.):117-122.
31. de Carvalho M., Pinto S., Swash M. Association of paraspinal and diaphragm denervation in ALS. Amyotrophic Lateral Sclerosis 2010, 11:63-66.
32. Dick T.E., Kong F.J., Berger A.J. Correlation of recruitment order with axonal conduction velocity for supraspinally driven diaphragmatic motor units. Journal of Neurophysiology 1987, 57:245-259.
33. Dupuis L., Gonzalez de Aguilar J.L., di Scala F., Rene F., de Tapia M., Pradat P.F., Lacomblez L., Seihlan D., Prinjha R., Walsh F.S., Meininger V., Loeffler J.P. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiology of Disease 2002, 10:358-365.
34. Dupuis L., Loeffler J.P. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models. Current Opinion in Pharmacology 2009, 9:341-346.
35. Dupuis L., Oudart H., Rene F., Gonzalez de Aguilar J.L., Loeffler J.P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:11159-11164.
36. Fallat R.J., Jewitt B., Bass M., Kamm B., Norris F.H. Spirometry in amyotrophic lateral sclerosis. Archives of Neurology 1979, 36:74-80.
37. Feldman J.L., Del Negro C.A., Gray P.A. Understanding the rhythm of breathing: so near, yet so far. Annual Review of Physiology 2013, 75:423-452.
38. Feldman J.L., Mitchell G.S., Nattie E.E. Breathing: rhythmicity, plasticity, chemosensitivity. Annual Review of Neuroscience 2003, 26:239-266.
39. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Experimental Neurology 2004, 185:232-240.
40. Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. The Journal of Neuroscience 2000, 20:2534-2542.
41. Gautier G., Verschueren A., Monnier A., Attarian S., Salort-Campana E., Pouget J. ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis. Amyotrophic Lateral Sclerosis 2010, 11:379-382.
42. Gerin C., Becquet D., Privat A. Direct evidence for the link between monoaminergic descending pathways and motor activity. I. A study with microdialysis probes implanted in the ventral funiculus of the spinal cord. Brain Research 1995, 704(2):191-201.
43. Gómez-Pinilla F., Ying Z., Opazo P., Roy R.R., Edgerton V.R. Differential regulation by exercise of BDNF and NT-3 in rat spinal cord and skeletal muscle. European Journal of Neuroscience 2001, 13(6):1078-1084.
44. Gómez-Pinilla F., Ying Z., Roy R.R., Molteni R., Edgerton V.R. Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity. Journal of Neurophysiology 2002, 88(5):2187-2195.
45. Gordon T., Hegedus J., Tam S.L. Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease. Neurological Research 2004, 26:174-185.
46. Gregory S.A. Evaluation and management of respiratory muscle dysfunction in ALS. NeuroRehabilitation 2007, 22:435-443.
47. Guillot S., Azzouz M., Deglon N., Zurn A., Aebischer P. Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1 (G93A) transgenic mice. Neurobiology of Disease 2004, 16:139-149.
48. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994, 264:1772-1775.
49. Hardiman O. Management of respiratory symptoms in ALS. Journal of Neurology 2011, 258:359-365.
50. Hardiman O., van den Berg L.H., Kiernan M.C. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nature Reviews. Neurology 2011, 7:639-649.
51. Hashimoto T., Matsubara S., Mochizuki Y., Tsuji S., Mizutani T., Oyanagi K. Forme fruste or incipient form of widespread-type amyotrophic lateral sclerosis, or motor neuron disease with pallido-nigro-luysian atrophy? An autopsy case report. Neuropathology 2008, 28:309-316.
52. Hayes J.A., Wang X., Del Negro C.A. Cumulative lesioning of respiratory interneurons disrupts and precludes motor rhythms in vitro. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:8286-8291.
53. Hegedus J., Putman C.T., Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease 2007, 28:154-164.
54. Hegedus J., Putman C.T., Gordon T. Progressive motor unit loss in the G93A mouse model of amyotrophic lateral sclerosis is unaffected by gender. Muscle and Nerve 2009, 39:318-327.
55. Hegedus J., Putman C.T., Tyreman N., Gordon T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. Journal of Physiology 2008, 586:3337-3351.
56. Hegland K.W., Bolser D.C., Davenport P.W. Volitional control of reflex cough. Journal of Applied Physiology 2012, 113:39-46.
57. Howland D.S., Liu J., She Y., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L.J., Cleveland D.W., Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proceedings of the National Academy of Sciences of the United States of America 2002, 99:1604-1609.
58. Jodkowski J.S., Viana F., Dick T.E., Berger A.J. Electrical properties of phrenic motoneurons in the cat: correlation with inspiratory drive. Journal of Neurophysiology 1987, 58:105-124.
59. Jodkowski J.S., Viana F., Dick T.E., Berger A.J. Repetitive firing properties of phrenic motoneurons in the cat. Journal of Neurophysiology 1988, 60:687-702.
60. Jokic N., Gonzalez de Aguilar J.L., Dimou L., Lin S., Fergani A., Ruegg M.A., Schwab M.E., Dupuis L., Loeffler J.P. The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Reports 2006, 7:1162-1167.
61. Jokic N., Gonzalez de Aguilar J.L., Pradat P.F., Dupuis L., Echaniz-Laguna A., Muller A., Dubourg O., Seilhean D., Hauw J.J., Loeffler J.P., Meininger V. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Annals of Neurology 2005, 57:553-556.
62. Kanning K.C., Kaplan A., Henderson C.E. Motor neuron diversity in development and disease. Annual Review of Neuroscience 2010, 33:409-440.
63. Kleopa K.A., Sherman M., Neal B., Romano G.J., Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. Journal of the Neurological Sciences 1999, 164(1):82-88.
64. Kobayashi Z., Tsuchiya K., Kubodera T., Shibata N., Arai T., Miura H., Ishikawa C., Kondo H., Ishizu H., Akiyama H., Mizusawa H. FALS with Gly72Ser mutation in SOD1 gene: report of a family including the first autopsy case. Journal of the Neurological Sciences 2011, 300:9-13.
65. Koliatsos V.E., Clatterbuck R.E., Winslow J.W., Cayouette M.H., Price D.L. Evidence that brain-derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron 1993, 10:359-367.
66. Krakora D., Macrander C., Suzuki M. Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis. Neurology Research International 2012, 379657.
67. Kuhnlein P., Gdynia H.J., Sperfeld A.D., Lindner-Pfleghar B., Ludolph A.C., Prosiegel M., Riecker A. Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nature clinical practice. Neurology 2008, 4:366-374.
68. Lechtzin N. Respiratory effects of amyotrophic lateral sclerosis: problems and solutions. Respiratory Care 2006, 51:871-881. (discussion 874-881).
69. Lechtzin N., Rothstein J., Clawson L., Diette G.B., Wiener C.M. Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment. Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology. Research Group on Motor Neuron Diseases 2002, 3:5-13.
70. Lechtzin N., Scott Y., Busse A.M., Clawson L.L., Kimball R., Wiener C.M. Early use of non-invasive ventilation prolongs survival in subjects with ALS. Amyotrophic Lateral Sclerosis 2007, 8:185-188.
71. Li J., Petajan J., Smith G., Bromberg M. Electromyography of sternocleidomastoid muscle in ALS: a prospective study. Muscle and Nerve 2002, 25:725-728.
72. Lie D.C., Weis J. GDNF expression is increased in denervated human skeletal muscle. Neuroscience Letters 1998, 250:87-90.
73. Liu R., Narla R.K., Kurinov I., Li B., Uckun F.M. Increased hydroxyl radical production and apoptosis in PC12 neuron cells expressing the gain-of-function mutant G93A SOD1 gene. Radiation Research 1999, 151:133-141.
74. Llado J., Haenggeli C., Pardo A., Wong V., Benson L., Coccia C., Rothstein J.D., Shefner J.M., Maragakis N.J. Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS. Neurobiology of Disease 2006, 21:110-118.
75. Lovett-Barr M.R., Satriotomo I., Muir G.D., Wilkerson J.E., Hoffman M.S., Vinit S., Mitchell G.S. Repetitive intermittent hypoxia induces respiratory and somatic motor recovery after chronic cervical spinal injury. The Journal of Neuroscience 2012, 32:3591-3600.
76. Ludolph A.C., Knirsch U. Problems and pitfalls in the diagnosis of ALS. Journal of the Neurological Sciences 1999, 165(Suppl. 1):S14L S20.
77. Lyall R.A., Donaldson N., Polkey M.I., Leigh P.N., Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001, 124:2000-2013.
78. MacIntosh B.R., Gardiner P.F., McComas A.J. Skeletal Muscle: Form and Function 2006, Human Kinetics, Champaign, Illinois. 2nd ed.
79. Mahamed S., Mitchell G.S. Respiratory long-term facilitation: too much or too little of a good thing?. Advances in Experimental Medicine and Biology 2008, 605:224-227.
80. Mantilla C.B., Seven Y.B., Zhan W.Z., Sieck G.C. Diaphragm motor unit recruitment in rats. Respiratory Physiology & Neurobiology 2010, 173:101-106.
81. Marti-Fabregas J., Dourado M., Sanchis J., Miralda R., Pradas J., Illa I. Respiratory function deterioration is not time-linked with upper-limb onset in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica 1995, 92:261-264.
82. Mattson M.P., Cutler R.G., Camandola S. Energy intake and amyotrophic lateral sclerosis. Neuromolecular Medicine 2007, 9:17-20.
83. Mayeux R. Epidemiology of neurodegeneration. Annual Review of Neuroscience 2003, 26:81-104.
84. McCrimmon D.R., Ramirez J.M., Alford S., Zuperku E.J. Unraveling the mechanism for respiratory rhythm generation. BioEssays 2000, 22:6-9.
85. McKay L.C., Janczewski W.A., Feldman J.L. Sleep-disordered breathing after targeted ablation of preBotzinger complex neurons. Nature Neuroscience 2005, 8:1142-1144.
86. Miscio G., Gukov B., Pisano F., Mazzini L., Baudo S., Salvadori A., Mauro A. The cortico-diaphragmatic pathway involvement in amyotrophic lateral sclerosis: neurophysiological, respiratory and clinical considerations. Journal of the Neurological Sciences 2006, 251:10-16.
87. Mitchell G.S., Baker T.L., Nanda S.A., Fuller D.D., Zabka A.G., Hodgeman B.A., Bavis R.W., Mack K.J., Olson E.B. Invited review: intermittent hypoxia and respiratory plasticity. Journal of Applied Physiology 2001, 90:2466-2475.
88. - with disease progression in ALS. Journal of the Neurological Sciences 2011, 307:74-78.
89. Motoi Y., Satoh K., Matsumine H., Wakiya M., Mori H., Shirai T., Kondo T., Mizuno Y. A 49-year-old man with progressive bulbar palsy and respiratory failure. No to shinkei 1998, 50:93-100.
90. Mustfa N., Walsh E., Bryant V., Lyall R.A., Addington-Hall J., Goldstein L.H., Donaldson N., Polkey M.I., Moxham J., Leigh P.N. The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology 2006, 66:1211-1217.
91. Nagai M., Aoki M., Miyoshi I., Kato M., Pasinelli P., Kasai N., Brown R.H., Itoyama Y. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. The Journal of Neuroscience 2001, 21:9246-9254.
92. Nashold L.J. Respiratory Motor Neuron Survival and Plasticity in a Rodent Model of Familial Amyotrophic Lateral Sclerosis 2011, University of Wisconsin, Madison, WI, (Ph.D. dissertation).
93. Nashold L.J., Wilkerson J.E., Satriotomo I., Dale E.A., Svendsen C.N., Mitchell G.S. Phrenic, but not hypoglossal, motor output is diminished in a rat model of amyotrophic lateral sclerosis (ALS). FASEB Journal 2006, 20:A1212.
94. Nichols N.L., Gowing G., Satriotomo I., Nashold L.J., Dale E.A., Suzuki M., Avalos P., Mulcrone P.L., McHugh J., Svendsen C.N., Mitchell G.S. Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis. American Journal of Respiratory and Critical Care Medicine 2013, 187:535-542.
95. Nichols N.L., Mitchell G.S. Enhanced phrenic but not XII long-term facilitation (LTF) following acute intermittent hypoxia (AIH) in a rat model of amyotrophic lateral sclerosis (ALS). FASEB Journal 2010, 24:799.9.
96. Obal I., Engelhardt J.I., Siklos L. Axotomy induces contrasting changes in calcium and calcium-binding proteins in oculomotor and hypoglossal nuclei of Balb/c mice. Journal of Comparative Neurology 2006, 499:17-32.
97. Oliver D. The quality of care and symptom control-the effects on the terminal phase of ALS/MND. Journal of the Neurological Sciences 1996, 139(Suppl.):134-136.
98. Palmowski A., Jost W.H., Prudlo J., Osterhage J., Kasmann B., Schimrigk K., Ruprecht K.W. Eye movement in amyotrophic lateral sclerosis: a longitudinal study. German Journal of Ophthalmology 1995, 4:355-362.
99. Park J.H., Kang S.W., Lee S.C., Choi W.A., Kim D.H. How respiratory muscle strength correlates with cough capacity in patients with respiratory muscle weakness. Yonsei Medical Journal 2010, 51:392-397.
100. Pellegrino C., Franzini C. An electron microscope study of denervation atrophy in red and white skeletal muscle fibers. Journal of Cell Biology 1963, 17:327-349.
101. Pinto S., Geraldes R., Vaz N., Pinto A., de Carvalho M. Changes of the phrenic nerve motor response in amyotrophic lateral sclerosis: longitudinal study. Clinical Neurophysiology 2009, 120:2082-2085.
102. Pinto S., Pinto A., De Carvalho M. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?. Europa Medicophysica 2007, 43:505-509.
103. Pinto A.C., Alves M., Nogueira A., Evangelista T., Carvalho J., Coelho A., deCarvalho M., Sales-Luís M.L. Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise?. Journal of the Neurological Sciences 1999, 169(1-2):69-75.
104. Pradat P.F., Bruneteau G., Gonzalez de Aguilar J.L., Dupuis L., Jokic N., Salachas F., Le Forestier N., Echaniz-Laguna A., Dubourg O., Hauw J.J., Tranchant C., Loeffler J.P., Meininger V. Muscle Nogo-A expression is a prognostic marker in lower motor neuron syndromes. Annals of Neurology 2007, 62:15-20.
105. Raibon E., Todd L.M., Moller T. Glial cells in ALS: the missing link?. Physical Medicine and Rehabilitation Clinics of North America 2008, 19:441-459. vii-viii.
106. Ramirez J.M., Schwarzacher S.W., Pierrefiche O., Olivera B.M., Richter D.W. Selective lesioning of the cat pre-Botzinger complex in vivo eliminates breathing but not gasping. Journal of Physiology 1998, 507(Pt 3):895-907.
107. Reid W.D., Brown J.A., Konnyu K.J., Rurak J.M., Sakakibara B.M. Physiotherapy secretion removal techniques in people with spinal cord injury: a systematic review. The Journal of Spinal Cord Medicine 2010, 33:353-370.
108. Rekling J.C., Feldman J.L. PreBotzinger complex and pacemaker neurons: hypothesized site and kernel for respiratory rhythm generation. Annual Review of Physiology 1998, 60:385-405.
109. Rekling J.C., Shao X.M., Feldman J.L. Electrical coupling and excitatory synaptic transmission between rhythmogenic respiratory neurons in the preBotzinger complex. The Journal of Neuroscience 2000, 20:RC113.
110. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
111. Ross H.H., Sandhu M.S., Cheung T.F., Fitzpatrick G.M., Sher W.J., Tiemeier A.J., Laywell E.D., Fuller D.D. In vivo intermittent hypoxia elicits enhanced expansion and neuronal differentiation in cultured neural progenitors. Experimental Neurology 2012, 235:238-245.
112. Rothstein J.D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Annals of Neurology 2009, 65(Suppl. 1):S3L S9.
113. Sakuma K., Watanabe K., Sano M., Uramoto I., Nakano H., Li Y.J., Kaneda S., Sorimachi Y., Yoshimoto K., Yasuhara M., Totsuka T. A possible role for BDNF, NT-4 and TrkB in the spinal cord and muscle of rat subjected to mechanical overload, bupivacaine injection and axotomy. Brain Research 2001, 907:1-19.
114. Sakuma K., Yamaguchi A. The recent understanding of the neurotrophin's role in skeletal muscle adaptation. Journal of Biomedicine & Biotechnology 2011, 2011:201696.
115. Sasaki S., Warita H., Komori T., Murakami T., Abe K., Iwata M. Parvalbumin and calbindin D-28k immunoreactivity in transgenic mice with a G93A mutant SOD1 gene. Brain Research 2006, 1083:196-203.
116. Satriotomo I., Dale E.A., Dahlberg J.M., Mitchell G.S. Repetitive acute intermittent hypoxia increases expression of proteins associated with plasticity in the phrenic motor nucleus. Experimental Neurology 2012, 237:103-115.
117. Schmalbruch H., Lewis D.M. Dynamics of nuclei of muscle fibers and connective tissue cells in normal and denervated rat muscles. Muscle and Nerve 2000, 23:617-626.
118. Schmidt E.P., Drachman D.B., Wiener C.M., Clawson L., Kimball R., Lechtzin N. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle and Nerve 2006, 33:127-132.
119. Shefner J., Cedarbaum J.M., Cudkowicz M.E., Maragakis N., Lee J., Jones D., Watson M.L., Mahoney K., Chen M., Saikali K., Mao J., Russell A.J., Hansen R.L., Malik F., Wolff A.A. Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 2012, 13:430-438.
120. Shimizu T., Komori T., Kugio Y., Fujimaki Y., Oyanagi K., Hayashi H. Electrophysiological assessment of corticorespiratory pathway function in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 2010, 11:57-62.
121. Sieck G.C. Physiological effects of diaphragm muscle denervation and disuse. Clinics in Chest Medicine 1994, 15:641-659.
122. Similowski T., Attali V., Bensimon G., Salachas F., Mehiri S., Arnulf I., Lacomblez L., Zelter M., Meininger V., Derenne J.P. Diaphragmatic dysfunction and dyspnoea in amyotrophic lateral sclerosis. The European Respiratory Journal 2000, 15:332-337.
123. Smith P.E., Calverley P.M., Edwards R.H., Evans G.A., Campbell E.J. Practical problems in the respiratory care of patients with muscular dystrophy. The New England Journal of Medicine 1987, 316:1197-1205.
124. Smittkamp S.E., Spalding H.N., Brown J.W., Gupte A.A., Chen J., Nishimune H., Geiger P.C., Stanford J.A. Measures of bulbar and spinal motor function, muscle innervation, and mitochondrial function in ALS rats. Behavioural Brain Research 2010, 211:48-57.
125. Stewart H., Eisen A., Road J., Mezei M., Weber M. Electromyography of respiratory muscles in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 2001, 191:67-73.
126. Stonnington H.H., Engel A.G. Normal and denervated muscle. A morphometric study of fine structure. Neurology 1973, 23:714-724.
127. Stya M., Axelrod D. Mobility of extrajunctional acetylcholine receptors on denervated adult muscle fibers. The Journal of Neuroscience 1984, 4:70-74.
128. Su M., Wakabayashi K., Tanno Y., Inuzuka T., Takahashi H. An autopsy case of amyotrophic lateral sclerosis with concomitant Alzheimer's and incidental Lewy body diseases. No to shinkei 1996, 48:931-936.
129. Sunderland S., Ray L.J. Denervation changes in mammalian striated muscle. Journal of Neurology, Neurosurgery, and Psychiatry 1950, 13:159-177.
130. Suzuki M., McHugh J., Tork C., Shelley B., Hayes A., Bellantuono I., Aebischer P., Svendsen C.N. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Molecular Therapy 2008, 16:2002-2010.
131. Talakad N.S., Pradhan C., Nalini A., Thennarasu K., Raju T.R. Assessment of pulmonary function in amyotrophic lateral sclerosis. The Indian Journal of Chest Diseases & Allied Sciences 2009, 51:87-91.
132. Tankersley C.G., Haenggeli C., Rothstein J.D. Respiratory impairment in a mouse model of amyotrophic lateral sclerosis. Journal of Applied Physiology 2007, 102:926-932.
133. Trumbower R.D., Jayaraman A., Mitchell G.S., Rymer W.Z. Exposure to acute intermittent hypoxia augments somatic motor function in humans with incomplete spinal cord injury. Neurorehabilitation and Neural Repair 2012, 26:163-172.
134. Tsuchiya K., Takahashi M., Shiotsu H., Akiyama H., Haga C., Watabiki S., Taki K., Nakano I., Ikeda K. Sporadic amyotrophic lateral sclerosis with circumscribed temporal atrophy: a report of an autopsy case without dementia and with ubiquitinated intraneuronal inclusions. Neuropathology 2002, 22:308-316.
135. Turner M.R., Kiernan M.C. Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?. Amyotrophic Lateral Sclerosis 2012, 13:245-250.
136. Valdez G., Tapia J.C., Lichtman J.W., Fox M.A., Sanes J.R. Shared resistance to aging and ALS in neuromuscular junctions of specific muscles. PLoS ONE 2012, 7:e34640.
137. Vitacca M., Clini E., Facchetti D., Pagani M., Poloni M., Porta R., Ambrosino N. Breathing pattern and respiratory mechanics in patients with amyotrophic lateral sclerosis. The European Respiratory Journal 1997, 10:1614-1621.
138. Waldrop T.G., Eldridge F.L., Millhorn D.E. Prolonged post-stimulus inhibition of breathing following stimulation of afferents from muscle. Respiration Physiology 1982, 50:239-254.
139. Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995, 14:1105-1116.
140. Xu Y.S., Zheng J.Y., Zhang S., Fan D.S. Upper trapezius electromyography aids in the early diagnosis of bulbar involvement in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 2011, 12:345-348.